Literature DB >> 27402521

Redefining Gold Standard Testing for Diagnosing Leptospirosis: Further Evidence from a Well-Characterized, Flood-Related Outbreak in Sri Lanka.

Suneth B Agampodi1,2, Niroshan J Dahanayaka3,1, Karsten Nöckler4, Anne Mayer-Scholl4, Joseph M Vinetz5.   

Abstract

A gap in the leptospirosis field remains the lack of well-characterized sample collections that allow for comparison of new methods to standard ones. In the context of a flood-related outbreak of leptospirosis evaluated in Anuradhapura, Sri Lanka, a specimen bank was obtained with detailed metadata accompanied by gold standard diagnostic test results. Blood samples collected on admission and 14 days later from suspected cases of leptospirosis were tested using microscopic agglutination test (MAT) (17 serovars), an in-house enzyme-linked immunosorbent assay (ELISA) using a locally obtained strain of Leptospira kirschneri as sonicated antigen, a commercially available ELISA based on sonicated Leptospira biflexa, and a quantitative polymerase chain reaction (qPCR) assay targeting the pathogenic Leptospira-specific 16S rRNA gene. Of 62 patients presenting within the first 2 days of illness, 31 had confirmed leptospirosis based either on paired-sample MAT or qPCR. During the acute phase, qPCR was most sensitive, detecting 74% of definitively diagnosed cases; immunoglobulin G (IgG) ELISA (in-house), IgG ELISA (commercial), and MAT had sensitivities of 35.5%, 12.0%, and 22.6%, respectively, in detecting definitively diagnosed cases using acute phase serum. Of 40 patients with paired sera, 10 were qPCR positive. Of these, five samples were negative by paired-sample MAT. Of the 11 MAT-positive samples, only five were detected using qPCR confirming that both tests are needed for maximal sensitivity. Regional leptospiral serovar-specific IgG ELISA was superior to MAT. Knowing the regionally dominant serovars improves serological sensitivity in the analysis of acute specimens by ELISA, but qPCR was most sensitive in this patient population. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2016        PMID: 27402521      PMCID: PMC5014254          DOI: 10.4269/ajtmh.16-0033

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  The potential emergence of leptospirosis in Sri Lanka.

Authors:  Suneth Agampodi; Sharon J Peacock; Vasanthi Thevanesam
Journal:  Lancet Infect Dis       Date:  2009-09       Impact factor: 25.071

2.  Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira.

Authors:  Christian A Ganoza; Michael A Matthias; Mayuko Saito; Manuel Cespedes; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

Review 3.  The role of leptospirosis reference laboratories.

Authors:  Rudy A Hartskeerl; Lee D Smythe
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  [Leptospirosis: case-series report in a prison of the coast in Ecuador].

Authors:  D Valarezo-Sevilla; V Sarzosa-Terán
Journal:  Rev Esp Sanid Penit       Date:  2014

Review 5.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  Serological and genetic analysis of leptospirosis in patients with acute febrile illness in kandy, sri lanka.

Authors:  Nobuo Koizumi; Chandika D Gamage; Maki Muto; Senanayake A M Kularatne; B D Budagoda; R P Rajapakse; Hidehiko Tamashiro; Haruo Watanabe
Journal:  Jpn J Infect Dis       Date:  2009-11       Impact factor: 1.362

7.  Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis.

Authors:  Direk Limmathurotsakul; Elizabeth L Turner; Vanaporn Wuthiekanun; Janjira Thaipadungpanit; Yupin Suputtamongkol; Wirongrong Chierakul; Lee D Smythe; Nicholas P J Day; Ben Cooper; Sharon J Peacock
Journal:  Clin Infect Dis       Date:  2012-04-20       Impact factor: 9.079

8.  Determinants of leptospirosis in Sri Lanka: study protocol.

Authors:  Suneth B Agampodi; Dhanaseela B Nugegoda; Vasanthi Thevanesam
Journal:  BMC Infect Dis       Date:  2010-11-19       Impact factor: 3.090

9.  Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years.

Authors:  Paul R Torgerson; José E Hagan; Federico Costa; Juan Calcagno; Michael Kane; Martha S Martinez-Silveira; Marga G A Goris; Claudia Stein; Albert I Ko; Bernadette Abela-Ridder
Journal:  PLoS Negl Trop Dis       Date:  2015-10-02

Review 10.  Globalization of leptospirosis through travel and migration.

Authors:  Medhani Bandara; Mahesha Ananda; Kolitha Wickramage; Elisabeth Berger; Suneth Agampodi
Journal:  Global Health       Date:  2014-08-12       Impact factor: 4.185

View more
  14 in total

1.  Evaluation of different serological assays for early diagnosis of leptospirosis in Martinique (French West Indies).

Authors:  Christophe Courdurie; Yohann Le Govic; Pascale Bourhy; Dorothee Alexer; Karine Pailla; Rafaelle Theodose; Raymond Cesaire; Jacques Rosine; Patrick Hochedez; Claude Olive
Journal:  PLoS Negl Trop Dis       Date:  2017-06-23

2.  Comparison of the Serion IgM ELISA and Microscopic Agglutination Test for diagnosis of Leptospira spp. infections in sera from different geographical origins and estimation of Leptospira seroprevalence in the Wiwa indigenous population from Colombia.

Authors:  Anou Dreyfus; Marie-Thérèse Ruf; Marga Goris; Sven Poppert; Anne Mayer-Scholl; Nadine Loosli; Nadja S Bier; Daniel H Paris; Tshokey Tshokey; John Stenos; Eliharintsoa Rajaonarimirana; Gustavo Concha; Jorge Orozco; Johana Colorado; Andrés Aristizábal; Juan C Dib; Simone Kann
Journal:  PLoS Negl Trop Dis       Date:  2022-06-06

3.  Artificial intelligence in differentiating tropical infections: A step ahead.

Authors:  Shreelaxmi Shenoy; Asha K Rajan; Muhammed Rashid; Viji Pulikkel Chandran; Pooja Gopal Poojari; Vijayanarayana Kunhikatta; Dinesh Acharya; Sreedharan Nair; Muralidhar Varma; Girish Thunga
Journal:  PLoS Negl Trop Dis       Date:  2022-06-30

4.  Nucleic acid and antigen detection tests for leptospirosis.

Authors:  Bada Yang; Sophia G de Vries; Ahmed Ahmed; Benjamin J Visser; Ingeborg M Nagel; René Spijker; Martin P Grobusch; Rudy A Hartskeerl; Marga Ga Goris; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-08-01

5.  Estimating the burden of leptospirosis in Sri Lanka; a systematic review.

Authors:  Janith Warnasekara; Iresha Koralegedara; Suneth Agampodi
Journal:  BMC Infect Dis       Date:  2019-02-06       Impact factor: 3.090

6.  Optimizing the microscopic agglutination test (MAT) panel for the diagnosis of Leptospirosis in a low resource, hyper-endemic setting with varied microgeographic variation in reactivity.

Authors:  Dinesha Jayasundara; Chandika Gamage; Indika Senavirathna; Janith Warnasekara; Michael A Matthias; Joseph M Vinetz; Suneth Agampodi
Journal:  PLoS Negl Trop Dis       Date:  2021-07-01

7.  A Case-Control Study of Environmental and Occupational Risks of Leptospirosis in Sri Lanka.

Authors:  Marie Hellung Schønning; Matthew David Phelps; Janith Warnasekara; Suneth B Agampodi; Peter Furu
Journal:  Ecohealth       Date:  2019-11-09       Impact factor: 4.464

8.  Leptospiral 3-hydroxyacyl-CoA dehydrogenase as an early urinary biomarker of leptospirosis.

Authors:  Claudia Toma; Nobuo Koizumi; Tetsuya Kakita; Takayoshi Yamaguchi; Idam Hermawan; Naomi Higa; Tetsu Yamashiro
Journal:  Heliyon       Date:  2018-04-30

9.  Fatal Leptospira spp./Zika Virus Coinfection-Puerto Rico, 2016.

Authors:  Paige Neaterour; Aidsa Rivera; Renee L Galloway; Myriam Garcia Negrón; Brenda Rivera-Garcia; Tyler M Sharp
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

10.  Leptospirosis in Ukraine (Lviv Oblast): Clinical and Epidemiological Features.

Authors:  Olena Zubach; Tetiana Telegina; Oksana Semenyshyn; Lilya Vasiunets; Aleksander Zinchuk
Journal:  Vector Borne Zoonotic Dis       Date:  2018-10-18       Impact factor: 2.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.